- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:00 | XFRA CAPITAL ADJUSTMENT INFORMATION - 16.12.2025 | 107 | Xetra Newsboard | Das Instrument E7T AU000000AJX6 ALEXIUM INTERNATIONAL GRP EQUITY wird cum Kapitalmassnahme gehandelt am 16.12.2025 und ex Kapitalmassnahme am 17.12.2025 The instrument E7T AU000000AJX6 ALEXIUM INTERNATIONAL... ► Artikel lesen | |
| 09.12. | INIFY LABORATORIES AB: Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue | 1 | Cision News | ||
| 04.12. | Bulletin from the extraordinary general meeting of Inify Laboratories AB | 1 | Cision News | ||
| INIFY LABORATORIES Aktie jetzt für 0€ handeln | |||||
| 03.12. | INIFY LABORATORIES AB: Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue | 1 | Cision News | ||
| 28.11. | INIFY Laboratories AB: Financial calendar | 2 | Oslo Børs | ||
| 12.11. | INIFY Laboratories AB: Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 | 1 | Oslo Børs | ||
| 12.11. | INIFY Laboratories AB: Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million | - | Oslo Børs | ||
| 29.10. | INIFY Laboratories AB: Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 2 | Oslo Børs | ||
| 29.10. | INIFY LABORATORIES AB: Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 2 | Cision News | ||
| 29.08. | INIFY LABORATORIES AB: Inify cuts diagnostic waiting times by weeks - now entering the UK market | 2 | Cision News | ||
| 29.08. | INIFY LABORATORIES AB: Inify Laboratories - mandatory notification of trade | 2 | Cision News | ||
| 27.08. | INIFY LABORATORIES AB: Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK | 1 | Cision News | ||
| 26.06. | INIFY LABORATORIES AB: Inify Laboratories deliver diagnostics for its first patient case in the UK in collaboration with Parkside Frimley | 2 | Cision News |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 20,110 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,960 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| BETA BIONICS | 29,720 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CERIBELL | 21,900 | 0,00 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,300 | +0,83 % | FMC, Hugo Boss, Kontron, PVA TePla, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| FRESENIUS | 47,980 | -1,07 % | Fresenius-Aktie im Aufwind: "Neubewertung" erwartet | Die Aktie des Bad Homburger Gesundheitskonzerns Fresenius zählt zum Start in die neue Handelswoche zu den stärksten Werten im deutschen Leitindex. Ein weiteres Lob von Analystenseite sorgt für positive... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,650 | +0,61 % | Aktien Frankfurt Ausblick: Dax dürfte vor US-Zinsentscheidung leicht schwächeln | FRANKFURT (dpa-AFX) - Vor der US-Leitzinsentscheidung an diesem Abend dürften die Anleger am deutschen Aktienmarkt einen Gang herunterschalten. Der Dax wurde rund eine Stunde vor Beginn des Börsenhandels... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 36,120 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| PROGYNY | 26,360 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,890 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| HEARTBEAM | 2,630 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| GENEDX | 150,62 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| QUIPT HOME MEDICAL | 3,500 | +34,10 % | Quipt Home Medical Corp.: Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management | Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's... ► Artikel lesen | |
| CLEARPOINT NEURO | 12,380 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,925 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
INIFY LABORATORIES AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,006 (-2,80 %) liegt der Kurs bei 0,208 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INIFY LABORATORIES AB finden Sie auf Wallstreet Online.